ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,837Medicare Part D Prescriptions Filled, Including Refills

Rank: 151 out of 973

$312K Total Retail Price of All Prescriptions

Rank: 339 out of 973

283 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 283 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 283 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 9,350 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

13% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LISINOPRIL 667 640 1 3
LEVOTHYROXINE SODIUM 531 508 2 2
FUROSEMIDE 437 422 3 6
RANITIDINE HCL 355 351 4 45
OMEPRAZOLE 334 334 5 5
AMLODIPINE BESYLATE 296 286 6 7
WARFARIN SODIUM 267 267 7 10
HYDROCODONE-ACETAMINOPHEN 261 240 S3 8 4
PAROXETINE HCL 237 225 9 66
DIGOXIN 232 219 10 32
ATENOLOL 231 227 11 16
CARVEDILOL 160 156 12 27
SERTRALINE HCL 142 138 13 21
LOVASTATIN 140 129 14 38
POTASSIUM CHLORIDE 131 131 15 9
PROPRANOLOL HCL 129 129 16 97
CARBIDOPA-LEVODOPA 116 116 17 71
TRAZODONE HCL 111 111 18 48
ALENDRONATE SODIUM 110 110 19 24
MIRTAZAPINE 110 102 19 43
METFORMIN HCL 108 96 21 8
SIMVASTATIN 102 102 22 1
LOSARTAN POTASSIUM 100 92 23 19
ATORVASTATIN CALCIUM 91 89 24 15
METOPROLOL SUCCINATE 91 91 24 17
RISPERIDONE 88 73 26 65
LANTUS 83 70 27 39
HUMALOG 77 76 28 127
CRESTOR 75 62 29 34
HYDRALAZINE HCL 72 72 30 157
DILTIAZEM 24HR ER 69 69 31 198
HYDROCHLOROTHIAZIDE 68 68 32 11
NABUMETONE 65 65 33 209
NIFEDICAL XL 63 63 34 333
SOTALOL 63 63 34 178
SUCRALFATE 62 62 36 131
ZOLPIDEM TARTRATE 61 46 37 20
METOPROLOL TARTRATE 58 58 38 13
SPIRONOLACTONE 57 57 39 49
ALLOPURINOL 55 55 40 29
OLANZAPINE 54 47 41 122
GLIPIZIDE 54 54 41 69
OXYBUTYNIN CHLORIDE 54 54 41 92
LABETALOL HCL 53 53 44 200
TRAMADOL HCL 53 52 44 18
TAMSULOSIN HCL 52 52 46 28
ESCITALOPRAM OXALATE 51 51 47 68
CITALOPRAM HBR 50 50 48 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.